MyFinsight
Home
Blog
About
ASCENIV
$102,921K
BIVIGAM
$19,419K
Intermediates And Other
$1,297K
ADMABio Manufacturing
Segment
$123,637K
Plasma Collection
Centers Segment
$723K
Material Reconciling
Items
$35K
(-2.78%↓ Y/Y)
Revenues
$124,395K
(1.98%↑ Y/Y)
Gross profit
$86,277K
(28.34%↑ Y/Y)
Cost of product
revenue
$38,118K
(-30.39%↓ Y/Y)
Income from operations
$52,445K
(22.54%↑ Y/Y)
Total operating
expenses
$33,832K
(38.49%↑ Y/Y)
Income before income
taxes
$50,237K
(25.29%↑ Y/Y)
Other income
(expense), net
-$2,208K
(18.25%↑ Y/Y)
Interest and other income
$1,238K
Selling, general and
administrative
$26,737K
(20.36%↑ Y/Y)
Research and development
$6,014K
(483.32%↑ Y/Y)
Plasma center
operating expenses
$1,026K
(-10.94%↓ Y/Y)
Amortization of intangible
assets
$55K
(71.88%↑ Y/Y)
Net income
$37,822K
(10.53%↑ Y/Y)
Provision for income taxes
$12,415K
(111.21%↑ Y/Y)
Interest expense
$3,424K
(86.70%↑ Y/Y)
Other expense
-$22K
(79.63%↑ Y/Y)
Back
Back
Income Statement
ADMA logo-svg
ADMA BIOLOGICS, INC. (ADMA)
ADMA logo-svg
ADMA BIOLOGICS, INC. (ADMA)
source: myfinsight.com